Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-001853
Filing Date
2017-01-24
Accepted
2017-01-24 16:59:50
Documents
2
Period of Report
2017-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2219
2 EX-24 DOCUMENT attachment1.htm EX-24 4062
  Complete submission text file 0000899243-17-001853.txt   7765
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, WALTHAM MA 02451
Business Address
Metzger Michael A (Reporting) CIK: 0001507220 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-28386 | Film No.: 17544306